There is no doubt that the complexity of laboratory revenue cycle management is unmatched in all of healthcare. With frequent regulatory and compliance rules changes, ever tightening margins, it is getting harder and harder for labs to be sure they are not leaving potential profits on the table.

To successfully navigate the financial and regulatory pitfalls of the current landscape, laboratories of all sizes must turn to revenue cycle management (RCM) as the fastest route to maximize reimbursement as the untapped reserve that leads to increased valuation.

This is a must-read for any laboratory CEO and CFO to have a unified understanding of RCM as well as any laboratory in an acquisition relationship that needs to rapidly realize synergies and quickly grow the top line of the acquisition to offset the typical post acquisition declines.

Download this white paper for a detailed analysis of how laboratories can maximize reimbursement to increase revenue and valuation operating margin.